Resilience is a biopharmaceutical and medicine manufacturing company specializing in biomanufacturing innovation. They focus on driving innovative biomanufacturing technologies for complex medicines like cell and gene therapies. Resilience offers end-to-end drug substance and drug product manufacturing solutions to ensure quick, safe, and scalable production of medicines. Their services include manufacturing solutions for biologics, vaccines, gene therapy, cell therapy, and nucleic acids. Resilience aims to broaden access to complex medicines and protect biopharmaceutical supply chains against disruption through their sustainable network of manufacturing solutions.